More about
Empagliflozin
News
November 07, 2022
3 min read
Save
‘Clear’ reduction in CV, renal outcomes with SGLT2 inhibitors across all high-risk groups
News
November 05, 2022
2 min read
Save
Empagliflozin lowers kidney disease progression, cardiovascular death in patients with CKD
News
September 29, 2022
2 min read
Save
Empagliflozin HF benefits consistent across albumin levels: EMPEROR-Pooled
News
June 17, 2022
7 min read
Save
A new horizon for guideline-directed medical therapy in HFpEF
News
June 14, 2022
2 min read
Save
Empagliflozin lowers risk for kidney stones in type 2 diabetes
News
June 03, 2022
2 min read
Save
ADA Standards of Care update reflects new data on CV, kidney disease in type 2 diabetes
News
April 07, 2022
3 min read
Save
Empagliflozin benefits acute HF regardless of baseline impairment: EMPULSE
News
April 05, 2022
2 min read
Save
Addition of empagliflozin improves daytime glucose in type 1 diabetes
News
March 21, 2022
3 min read
Save
Mineralocorticoid receptor antagonist use does not affect empagliflozin benefit in HFpEF
News
March 17, 2022
1 min read
Save